Wild-Type Human p53 Transactivates the Human Proliferating Cell Nuclear Antigen Promoter

Shivakumar, Chittari V., Brown, Doris R., Deb, Sumitra, Deb, Swati Palit·1995·Molecular and Cellular Biology
DOI 10.1128/mcb.15.12.6785

Cited by (120)

Items 101–120 of 120

  1. pZ402, an improved SV40-based shuttle vector containing a T-antigen mutant unable to interact with wild-type p53
    Eliyahu Kraus, Louise C. Strong, Michael A. Tainsky · 1998 · Gene
  2. p53 Modulation of DNA Topoisomerase IIα Gene Expression
    Ashish A. Joshi, Qingjian Wang, D. Parker Suttle · 2000 · Cell Biochemistry and Biophysics
  3. p53 protein activates the transcription of human proliferating cell nuclear antigen in response to 4-nitroquinoline N-oxide treatment
    Yuanyuan Li, Lei Wang, Shihua Li, Ting-Qing Guo, Xiuyang Guo, Peijun Yan, Ying Chen, Lingzhi Wang, Chang‐De Lu · 2004 · The International Journal of Biochemistry & Cell Biology
  4. POLYMERIZATION OF THE DNA BINDING FRAGMENT OF p53 ON DNA: ATOMIC FORCE MICROSCOPY STUDY
    Yuri L. Lyubchenko, Luda S. Shlyakhtenko, Akhilesh K. Nagaich, Ettore Appella, Rodney E. Harrington, Stuart M. Lindsay · 1998
  5. p53 protein and the response of human skin to UV
    David Decraene, Patrizia Agostinis, Annemie Pupe, Petra De Haes, Marjan Garmyn · 2001 · Comprehensive series in photosciences
  6. Silencing Ubiquitin-Specific Peptidase 10 Alleviates Persistent Corneal Epithelial Defect in Mice
    Arpan Banerjee, Mohammad Anjum Shaik, Christine Tilstra-Smith, Nileyma Castro, Jelissa Reynoso-García, Michael E. Zuber, Audrey M. Bernstein · 2025 · American Journal Of Pathology
  7. UV Response of Mammalian p53 Tumor Supressor Gene
    Tarja Mälkönen · 1999 · Työväentutkimus Vuosikirja
  8. The Functional and Clinical Consequences of TP53 Mutations in Cancer
    Nicholas William Fischer · 2019 · TSpace (University of Toronto)
  9. Extracellular Proliferating Cell Nuclear Antigen as a Marker and Therapeutic Target for Cancer Stem Cells.
    Nathan Horton · 2014 · Digital Commons @ UNT Health Science Center
  10. TP53 in Carcinogenesis and Cancer Prevention
    Emmanuelle Gormally, Pierre L. Hainaut · 2003 · Handbook of experimental pharmacology
  11. Trinucleotide Repeats (TNRs): DNA-Bindungssubstrate für Wildtyp und mutiertes p53 und Modulatoren der p53-abhängigen Transkription
    Korden Walter · 2005
  12. Molecular studies of coronavirus replication and pathogenesis
    Qisheng Li · 2007 · DR-NTU (Nanyang Technological University)
  13. RADIOSENSITIVITY AND CANCER-RELATED GENES
    Akihisa Takahashi, Takeo Ohnishi · 1997 · The Journal of JASTRO
  14. Differentiation and gene regulation
    1996 · Current Opinion in Genetics & Development
  15. Targeting MDM2, the antagonist of the tumor suppressor p53
    Anusha Sriraman · 2018 · eDiss (Georg-August-Universität Göttingen)
  16. P53
    Robin Hesketh · 1997 · Elsevier eBooks
  17. The MDM2 oncoprotein antagonizes Poly(ADP-ribosyl)ation
    Celeste Giansanti · 2023 · eDiss (Georg-August-Universität Göttingen)
  18. Chemopreventive Activities of Trigonella foenum graecum Against Hepatocellular Carcinoma Cell Line
    Biby Sara John, D Sophia, Ramamurthy V, Mathew Joe Prasad · 2023 · International Journal of Zoological Investigations
  19. Molecular Pathways of Drug Resistance
    Christos Tolis, Carlos Gil Ferreira, Herbert M. Pinedo, Giuseppe Giaccone · 2000 · Humana Press eBooks
  20. Untitled work
    2000 · 10.1002/1097-0215(20001015)88:2